Why Is Teradata Stock Falling on Wednesday? - Teradata (NYSE:TDC)
Teradata (TDC) reported Q2 adjusted EPS of 69 cents, above the 56-cent estimate, and sales of $410 million versus $397.1 million expected. For Q3, it guided adjusted EPS of 55 to 59 cents and sales of $391.0 to $399.4 million, both below estimates. FY2026 adjusted EPS was raised to $2.65-$2.73. Barclays cut its price forecast to $27. Shares fell 21.2% to $27.11.
How this was made

The 30-second read
Why it matters
Near-term repricing is driven by Q3 adjusted EPS and sales guidance coming in below consensus, despite a Q2 beat and an FY non-GAAP EPS increase.
Market read
Traders are likely focusing on the guidance gap versus Street estimates and the resulting momentum/technical breakdown rather than the Q2 beat alone.
What to watch
The article emphasizes technical weakness (below 20/50/200-day SMAs) which can amplify selling; traders may overreact if subsequent commentary clarifies drivers of the Q3 sales and EPS ranges.
Background
Teradata reported Q2 results and issued Q3 and FY 2026 guidance, alongside commentary about an Autonomous Knowledge Platform and agentic AI capabilities.
Ticker impact
Teradata beat Q2 adjusted EPS and sales but guided Q3 adjusted EPS and sales below Street estimates, driving the selloff.
Bearish bias for the next few sessions as traders reprice the Q3 outlook; any relief likely depends on follow-through from the raised FY non-GAAP EPS and free-cash-flow commentary.
The article’s newest concrete facts are the Q3 adjusted EPS range (55-59 cents vs 62 cents) and Q3 sales range ($391.040m-$399.360m vs $404.827m), which typically outweigh a prior-quarter beat. It also notes the stock is down sharply and below key moving averages, reinforcing momentum risk.
Market effects
Signals continued pressure on enterprise data/analytics software demand expectations, even when ARR and free cash flow are described as improving.
Primarily US large-cap software/IT services sentiment, with limited direct regional spillover described.
No explicit global macro or international catalyst beyond company-specific guidance.
Counterpoint
The company raised FY 2026 adjusted EPS guidance and highlighted ARR growth and free cash flow, suggesting the Q3 miss may be more timing-related than demand deterioration.
Key entities
- companyTeradata
NYSE-listed data and analytics software provider whose Q3 guidance miss is cited as the reason for the stock decline.
- analyst_firmBarclays
Maintained an Underweight rating and lowered its price forecast to $27 after the results.


